Stocks and Investing Stocks and Investing
Fri, May 3, 2024

Christopher Raymond Maintained (BPMC) at Hold with Increased Target to $104 on, May 3rd, 2024


Published on 2024-10-28 10:58:27 - WOPRAI, Christopher Raymond
  Print publication without navigation


Christopher Raymond of Piper Sandler, Maintained "Blueprint Medicines Corporation" (BPMC) at Hold with Increased Target from $78 to $104 on, May 3rd, 2024.

Christopher has made no other calls on BPMC in the last 4 months.



There are 2 other peers that have a rating on BPMC. Out of the 2 peers that are also analyzing BPMC, 0 agree with Christopher's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Christopher


  • Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $130 on, Friday, April 26th, 2024
  • David Nierengarten of "Wedbush" Reiterated at Buy and Held Target at $110 on, Friday, April 26th, 2024

Contributing Sources